Severe Acute Respiratory Syndrome (SARS)

Medical Author:
Medical Editor:

Severe acute respiratory syndrome (SARS) facts

  • SARS is a contagious respiratory disease first identified in 2002.


  • SARS is caused by a coronavirus (SARS-CoV) that exists in bats and civets in Southern China.


  • The infection is spread easily from person to person through respiratory droplets.


  • Infected people have symptoms of pneumonia, including fever and shortness of breath. Diarrhea may also occur.


  • Severely affected people experience respiratory failure and may need mechanical ventilation. Older people, pregnant women, and those with underlying illnesses are at higher risk for severe disease.


  • No cases of SARS have been diagnosed since 2004. SARS should be suspected in people with a compatible illness who work with SARS-CoV in the laboratory or who have gotten ill after exposure to bats or civets in Southern China.


  • If there are grounds for suspicion, respiratory secretions are sent for testing to reference laboratories or to the CDC.


  • There is no medication that is known to treat SARS. Treatment is supportive.


  • During the 2002 outbreak, approximately 25% of people had severe respiratory failure and 10% died.


  • The SARS outbreak in 2002 was controlled solely by using public-health measures such as wearing surgical masks, washing hands well, and isolating infected patients.


Patient Comments

Viewers share their comments

SARS - Causes Question: What caused SARS in someone you know?
SARS - Symptoms and Signs Question: What were the signs or symptoms of SARS in someone you know?
SARS - Treatment Question: What kinds of treatment were used for SARS in a friend or relative?

New Treatment for Coronavirus Shows Promise

A treatment for a new coronavirus that has caused 11 deaths, mostly in the Middle East, shows promise in early tests, U.S. government researchers report.

The investigators discovered that a combination of two antiviral drugs -- ribavirin and interferon-alpha 2b -- can stop the so-called nCoV coronavirus from multiplying in laboratory-grown cells. While the results suggest that this drug combination could be used to treat patients infected with nCoV, more research is needed to confirm these early findings.

SOURCE:
HealthDay News

Get the latest health and medical information delivered direct to your inbox FREE!